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4Abstract
An efficient CuI catalyst for the O-arylation of Benzaldoxime   with aryl iodide  has been 
developed.Here Benzaldooxime serves as an efficient for C-O cross-coupling thereby 
allowing for the preparation of O-aryloxime from simple aryl halide.This is a single step 
synthesis Short reaction times and broad substrate scope, including heteroaryl coupling 
partners, allow access to O-aryloximes that would be difficult to prepare in a single step by 
traditional methods. This one-step formation of the dN-O-Ar linkage givesaccess to a range 
of oxime ethers in good to moderate yields.
5Introduction
O-aryloxime ethers are valuable synthetic targets molecules due to their wide occurrence in a 
variety of bioactive oxime linkage, as a synthon for the synthesis of benzofurans,1
benzisoxazoles, and benzoxazoles.2 The bisoaryl oxime ethers act as a potent inhibitors of 
transthyratin amyloid fibril formations.3 The O-aryloxime ethers are key structural motifs in 
many drug scaffolds and bioactive compounds. The oxime ether moiety are present in a 
number of bioactive compounds and show broad spectrum biological activity like antiviral4,
anti-inflammatory5, antibiotics,6 antifungal7 and antidepressant5. The oxime ethers are present 
in a number of commercialized drugs like enviroxime, pifoxime, cefixime, pralidoxime, 
oxiconazole, and fluvoxamine8. O-aryl oxime ethers have potential application in medicinal 
and bioorganic chemistry. For example some act as inhibitors of protein chaperone Hsp 90,9
some others show good neuroleptic activities.10 The wide applications of oxime ethers in 
medicine, biology and chemistry made people interested for their synthesis.
The most common approach for the synthesis of oxime ethers is the condensation of 
aldehydes or ketones with O-aryloxyamines (Scheme 1). 
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Though the aldehydes and ketones are commercially available but O-aryloxyamines are 
required to synthesize prior to use which is relatively difficult. 
6Recently, transition metal catalyzed coupling reactions reveals as a useful strategy for 
the synthesis of C-C and C-hetero bonds. Despite the significant progress in this area, O-
arylation of oximes is rarely reported. For e.g. Maitra and Co-workers reported a ligand 
assisted Cu catalysed route for the synthesis of o-aryl oxime ethers (Scheme-2)
Schem-2
Recently Cai and co-workers reported the polymer supported copper complex for the 
synthesis of O-aryloxime ethers by the cross-coupling of oximes with aryl boronic acids
(Scheme 3).12
Scheme-3
Buchwald reported the Pd-catalyzed O-arylation of Ethyl Acetohydroximate for the synthesis 
of O-arylhydroxylamines (Scheme 4)13
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7Meyer and co-workers synthesized the O-aryloxime ethers by the Copper acetate catalyzed 
cross-coupling of oximes with phenyl boronic acids (Scheme 5).14
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The presence of limited reports on o-arylation of oximes reasons us to consider this project 
for our training purpose. We follow the procedure reported by Maitra et al. for the C-O 
cross-coupling reaction to yield O-aryl oxime.
We prepared the oximes by following the reported procedures (Scheme-6).
Benzaldehyde reacted with hydroxyl amine hydrochloride in methanol at room temperature 
to afford the oxime.
Scheme-5
           
Procedure:
0.48 mL (4.52 mmol) of benzaldehyde was stirred in methanol (10 mL) in a 100 mL one-
neck round bottom flask. 375 mg (4.31 mmol) of hydroxylamine hydrochloride was added to 
the above mixture and the stirring was continued for over night at room temperature. Water 
was added to the resulting mixture and the organic layer was extracted with dichloromethane 
and concentrated under vacuo. The crude mixture was purified by column chromatography to 
get the pure compound, benzaldoxime as a yellow oil.
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+ NH2OH.HCl
MeOH.rt
N
OH
8Benzaldoxime undergo cross-coupling reaction with iodobenzene in presence of CuI lead to 
the O-aryl oxime in  40% yield as crystalline solid (Scheme 6).
Scheme-6
Preparation of synthesis of o-aryl oxime
In a 50 ml two neck round bottom flask 1 gm (8.26mmol) oxime was added in dry toluene. 
Followed by the addition of 5.38 gm (16.5 mmol) of Cs2CO3 under inert atmosphere. The 
resulting mixture was stirred at 110 0C for 15 min. To the resulting yellow suspension 0.92 
mL (8.26 mmol) of iodo benzene was added followed by 0.29 gm (1.62 mmol) of 1,10-
phenanthroline and 0.69 gm (2.47 mmol) of sodium potassium tartarate. After 5 min 0.314 
gm (1.65 mmol) of CuI was added to the above mixture. The resulting mixture was refluxed 
for overnight. After completion of the reaction the solution was filtered and water was added 
to the filtrate. The organic layer was extracted with dichloromethane and the solvent was 
evaporated by rotary evaporator. The crude mixture was purified by column chromatography 
using ethyl acetate and petroleum ether as the eluent to get the pure compound. M. P.: 1100C
The product has been characterised by 1 H-NMR (CDCl3, ppmm, 2H), 
m, 7H), m, 1H)
The product was also characterised by 13C-NMR
13C-
NMR(CDCI3,ppmsdd)s),129.98(d)d)
129.08(d)d)d)
But this NMR data is not matched with the reported data given by Maitra and co workers
(Ref. De, P.; Pandurangan, K. N.; Maitra, U., Wailes S. Org. Lett., 2007, 9, 2767)                                                                     
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9In conclusion we repeated the procedure reported by Maitra et. al. for the synthesis of O-
arylation of oximes.
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